Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF): a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial

Saved in:
Bibliographic Details
Main Authors: Behr, Jürgen (Author) , Prasse, Antje (Author) , Kreuter, Michael (Author)
Format: Article (Journal) Book/Monograph
Language:English
Published: London BioMed Central 2017
DOI:10.1186/s12890-017-0462-y
Online Access:Resolving-System, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12890-017-0462-y
Resolving-System, kostenfrei, Volltext: http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-234946
Get full text
Author Notes:Jürgen Behr; Petra Neuser; Antje Prasse; Michael Kreuter; Klaus Rabe; Carmen Schade-Brittinger; Jasmin Wagner; Andreas Günther
Description
Item Description:Aus: BMC Pulmonary Medicine, 17 (2017), Nr. 122. pp. 1-9. ISSN 1471-2466
Physical Description:Online Resource
DOI:10.1186/s12890-017-0462-y